NCT05184842 Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML Status RECRUITING Phase PHASE2
NCT05133128 An Experimental Medicine Clinical Study to Compare Peripheral Immune System From Subjects Without Cancer Diagnosis and Patients With Solid Tumours. Status TERMINATED Phase NA
NCT05085249 Improving Goal Directed Medical Therapy for Device Clinic Patients With Reduced EF at UOHI: a QI Initiative (VIGILANT) Status COMPLETED Phase N/A
NCT05062889 Exploiting Circulating Tumour DNA to Intensify the Postoperative Treatment Resected Colon Cancer Patients Status SUSPENDED Phase PHASE2
NCT04965870 A Study of Trifluridine/ Tipiracil in Chemorefractory mCRC in Greece Status COMPLETED Phase N/A
NCT04894123 Cardiovascular Events From Trifluridine/Tipiracil +/- Oxaliplatin in Colorectal/Oesogastric Adenocarcinoma Patients Status TERMINATED Phase PHASE2
NCT04617457 Chemotherapy and Surgical Resection in Patients With Hepatic Oligometastatic Adenocarcinoma of the Pancreas Status RECRUITING Phase PHASE2
NCT04489173 TAS102 in Patients With ER-positive, HER2-negative Advanced Breast Cancer Status COMPLETED Phase PHASE2
NCT04307576 A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Status RECRUITING Phase PHASE3
NCT04059562 Trifluridine/Tipiracil in Combination With Irinotecan as a Second Line Therapy in Patients With Cholangiocarcinoma Status COMPLETED Phase PHASE2
NCT03980080 Phase I Study to Assess the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of OSE-127 in Healthy Subjects Status COMPLETED Phase PHASE1
NCT03841383 Association Between Coronary Flow Reserve and BH4 Levels in High CV Risk Status COMPLETED Phase N/A
NCT03837977 Second-line Therapy for Patients With Progressive Poorly Differentiated Extra-pulmonary Neuroendocrine Carcinoma Status COMPLETED Phase PHASE2
NCT03764553 Liposomal iRInotecan, Carboplatin or oXaliplatin for Esophagogastric Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03719924 Nal-iri/lv5-fu Versus Paclitaxel as Second Line Therapy in Patients With Metastatic Oesophageal Squamous Cell Carcinoma Status COMPLETED Phase PHASE2
NCT03488420 Canadian EdoxAban(Lixiana®) Registry in Patients With ATrial Fibrillation/Flutter With Confirmed ValvUlar HeaRt DiseasE Status COMPLETED Phase N/A
NCT03117751 Total Therapy XVII for Newly Diagnosed Patients With Acute Lymphoblastic Leukemia and Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3